EASL-Burden of Liver Disease in Europe: Looks at leading causes of cirrhosis and primary liver cancer in Europe
- File Under HCV News
Following an event hosted by Stephen Hughes MEP at the European Parliament in Brussels today - February 20th, 2013 - the new EASL publication 'The Burden of Liver Disease in Europe: A review of Available Epidemiological Data' has been published by EASL.
The report which can be viewed and downloaded below reviews 260 epidemiological studies published in the last five years to survey the current state of evidence on the burden of liver disease in Europe and its causes. The report looks at the leading causes of cirrhosis and primary liver cancer in Europe: alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity. In addition, the report also looks at the incidence and prevalence of Hepatitis A, D, and E, of Drug induced liver injuries (DILI), Haemochromatosis, Autoimmune hepatitis, Primary biliary cirrhosis (PBC) and Primary sclerosing cholangitis (PSC).
For further information please contact Margaret Walker, EASL Director of EU Public Affairs at firstname.lastname@example.org
- Liver disease is estimated to affect 6% of the EU’s population
- Liver disease is reported to be the EU’s 5th most common cause of death, accounting for at least one in six deaths
- Liver cancer is the third most common cause of cancer-related mortality globally
- Hepatitis, the most common liver disease, is estimated to affect over 10 million people in Europe
- Alcohol consumption is the 3rd largest cause of early death and illness in the EU, just behind tobacco and high blood pressure. Excessive and chronic alcohol consumption leads to increased prevalence of liver cirrhosis and liver cancer.